Jakimczuk, A.; Kalaska, B.; Kamiński, K.; Miklosz, J.; Yusa, S.-I.; Pawlak, D.; Szczubiałka, K.; Mogielnicki, A.
Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. J. Clin. Med. 2022, 11, 2236.
https://doi.org/10.3390/jcm11082236
AMA Style
Jakimczuk A, Kalaska B, Kamiński K, Miklosz J, Yusa S-I, Pawlak D, Szczubiałka K, Mogielnicki A.
Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. Journal of Clinical Medicine. 2022; 11(8):2236.
https://doi.org/10.3390/jcm11082236
Chicago/Turabian Style
Jakimczuk, Aleksandra, Bartlomiej Kalaska, Kamil Kamiński, Joanna Miklosz, Shin-Ichi Yusa, Dariusz Pawlak, Krzysztof Szczubiałka, and Andrzej Mogielnicki.
2022. "Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins" Journal of Clinical Medicine 11, no. 8: 2236.
https://doi.org/10.3390/jcm11082236
APA Style
Jakimczuk, A., Kalaska, B., Kamiński, K., Miklosz, J., Yusa, S.-I., Pawlak, D., Szczubiałka, K., & Mogielnicki, A.
(2022). Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. Journal of Clinical Medicine, 11(8), 2236.
https://doi.org/10.3390/jcm11082236